Skip to main navigation Skip to search Skip to main content

Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens: A case report

  • Richar Rodríguez-Hidalgo
  • , Arturo Carpio
  • , Erwin Van Den Enden
  • , Washington Benítez-Ortiz
  • Universidad Central del Ecuador
  • Universidad de Cuenca
  • Columbia University
  • Institute of Tropical Medicine Antwerp

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Background: Parenchymal neurocysticercosis is a frequent cause of seizures in areas endemic for Taenia solium. At present there is scarce data on the evolution of the levels of circulating metacestodal antigen before, during and after treatment with anthelmintic drugs. Case presentation: A patient with paucisymptomatic neurocysticercosis (NCC) diagnosed by Ag-ELISA, and confirmed by MRI images, was treated with praziquantel, albendazole and dexamethasone. The level of circulating T. solium antigen was determined weekly. Circulating antigen disappeared from his blood within 14 days after the start of the treatment and correlated with the involution of the cysticerci in the brain shown by imaging. Seventeen years later, the patient has not shown any side effect nor symptoms related to the treatment or to NCC. Conclusions: If this encouraging finding is confirmed in a larger series of patients, this technique could be used to determine parasitological cure after treatment and might complement or sometimes replace sequential MRI-imaging of the brain.

Original languageEnglish
Article number52
JournalBMC Neurology
Volume19
Issue number1
DOIs
StatePublished - 3 Apr 2019
Externally publishedYes

Keywords

  • Albendazole
  • Neurocysticercosis
  • Praziquantel
  • Taenia solium
  • Treatment

Fingerprint

Dive into the research topics of 'Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens: A case report'. Together they form a unique fingerprint.

Cite this